# Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

> **NCT07389057** · NA · RECRUITING · sponsor: **Noguchi Memorial Institute for Medical Research** · enrollment: 9000 (estimated)

## Conditions studied

- Malaria Asymptomatic Parasitaemia
- Malaria Falciparum
- Malaria Infection
- Malaria Transmission

## Interventions

- **DRUG:** DHAP
- **DRUG:** Single low dose PQ

## Key facts

- **NCT ID:** NCT07389057
- **Lead sponsor:** Noguchi Memorial Institute for Medical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 9000 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07389057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07389057, "Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07389057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*